©The Author(s) 2026.
World J Gastroenterol. Jan 7, 2026; 32(1): 112496
Published online Jan 7, 2026. doi: 10.3748/wjg.v32.i1.112496
Published online Jan 7, 2026. doi: 10.3748/wjg.v32.i1.112496
| Genes | Function | Associated disorders |
| Genes involved in DNA repair and genomic stability[10] | ||
| MLH1, MSH2, MSH6, PMS2, EPCAM | Mismatch repair (MMR) system | Lynch syndrome colorectal, gastric, pancreatic cancer |
| MUTYH | Base excision repair | MUTYH-associated polyposis |
| BRCA1/BRCA2, ATM, PALB2 | Double-strand break repair | Familial pancreatic and gastric cancers |
| TP53 | Tumor suppressor, DNA damage response | CRC, gastric, pancreatic, hepatocellular carcinoma |
| Genes involved in cell adhesion and structural integrity[11] | ||
| CDH1 | E-cadherin (cell-cell adhesion) | Hereditary diffuse gastric cancer |
| CTNNA1 | Catenin alpha-1 (adherens junctions) | HDGC |
| SMAD4, BMPR1A | TGF-β pathway mediators | Juvenile polyposis syndrome, pancreatic cancer |
| Genes regulating inflammation and immune response[12] | ||
| NOD2 | Innate immunity, bacterial sensing | Crohn’s disease |
| IL23R, IL10, IL12B | Cytokine signaling | IBD susceptibility |
| IRGM, ATG16 L1 | Autophagy genes | Crohn’s disease |
| HLA-DQA1/HLA-DQB1 | Antigen presentation | Celiac disease |
| TLR4, TLR9 | Pattern recognition receptors | Functional dyspepsia, IBD |
| Genes involved in bile acid transport and cholestasis[13] | ||
| ABCB11 | Bile salt export pump | PFIC2, BRIC |
| ABCC2 (MRP2) | Bile excretion | Dubin-Johnson syndrome |
| ATP8B1 | Phospholipid transporter | PFIC1 |
| TJP2 | Tight junction protein | PFIC4 |
| Genes in neuronal/gut motility and enteric nervous system[14] | ||
| RET, EDNRB, GDNF | ENS development | Hirschsprung’s disease |
| SCN5A | Sodium channel in ICCs/ENS | IBS with constipation |
| NEUROG3 | Enteroendocrine differentiation | Congenital malabsorptive diarrhoea |
| Genes affecting nutrient absorption and metabolism[15] | ||
| LCT | Lactase enzyme | Lactose intolerance |
| SAR1B | Chylomicron transport | Chylomicron retention disease |
| SLC26A3 | Cl-/HCO3- exchange | Congenital chloride diarrhea |
| SLC5A1 (SGLT1) | Glucose transport | Glucose-galactose malabsorption |
| Genes in oncogenic signaling and growth factors[15] | ||
| KRAS, NRAS | MAPK signaling | CRC, pancreatic cancer |
| BRAF | Downstream of KRAS | CRC (BRAF V600E in MSI tumors) |
| PIK3CA | PI3K/AKT pathway | CRC, gastric cancer |
| EGFR, HER2 (ERBB2) | Receptor tyrosine kinases | Gastric, colorectal cancers |
| FGFR2, IDH1/IDH2 | Growth factor pathways | Cholangiocarcinoma |
| Genes related to epigenetic and transcriptional regulation[16] | ||
| ARID1A | Chromatin remodeling | Biliary cancer, CRC, gastric |
| MLH3, MSH3 | Mismatch repair (minor MMR genes) | Polyposis syndromes |
| TET2, DNMT3A | DNA methylation regulation | CRC and inflammatory epigenetic signatures |
- Citation: Kumar A, Sarangi Y, Kaw P. Gene, genetics and genetic medicines in gastroenterology: Current status and its future. World J Gastroenterol 2026; 32(1): 112496
- URL: https://www.wjgnet.com/1007-9327/full/v32/i1/112496.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i1.112496